Therefore, NKILA could exert a context-dependent role as a regulator of NFκB signaling and metastasis, suggesting the potential of this lncRNA as a therapeutic target to modulate the function of tumor-specific T cells in BC. The gene discussed is NKILA; the disease is breast cancer.